NOELLE HANAKO EBEL

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Transplant Hepatology PALO ALTO, CA NPI 1376834697

General Payments — all program years on this page

$79,767.34

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $25,064.95 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Mirum Pharmaceuticals, Inc. $15,271.0915
Ipsen Biopharmaceuticals, Inc $9,793.864

By program year

Program yearAmountRecords
2022 $17,950.007
2023 $36,752.3920
2024 $25,064.9519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091969157 Ipsen Biopharmaceuticals, Inc $3,320.00 08/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1091969159 Ipsen Biopharmaceuticals, Inc $2,943.50 05/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1091969161 Ipsen Biopharmaceuticals, Inc $2,943.50 07/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1091969163 Ipsen Biopharmaceuticals, Inc $586.86 04/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323981 Mirum Pharmaceuticals, Inc. $91.99 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323983 Mirum Pharmaceuticals, Inc. $3,080.00 02/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123323985 Mirum Pharmaceuticals, Inc. $223.78 02/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323987 Mirum Pharmaceuticals, Inc. $1,050.00 04/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123323989 Mirum Pharmaceuticals, Inc. $23.36 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323991 Mirum Pharmaceuticals, Inc. $200.56 10/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323993 Mirum Pharmaceuticals, Inc. $27.12 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323995 Mirum Pharmaceuticals, Inc. $16.00 10/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323997 Mirum Pharmaceuticals, Inc. $3,080.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123323999 Mirum Pharmaceuticals, Inc. $124.99 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123324001 Mirum Pharmaceuticals, Inc. $75.00 10/23/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123324003 Mirum Pharmaceuticals, Inc. $27.81 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123324005 Mirum Pharmaceuticals, Inc. $3,600.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123324007 Mirum Pharmaceuticals, Inc. $3,600.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123324009 Mirum Pharmaceuticals, Inc. $50.48 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.